chembio.comChembio Diagnostics, Inc. – Our Products Help Prevent the Spread of Infectious Diseases

Hit enter to search or ESC to closesearch Menu Products Infectious Diseases DPP ® HIV-Syphilis DPP ® HIV 1/2 Assay DPP ® Syphilis Screen & Confirm HIV 1/2 STAT PAK ® Assay SURE CHECK ® HIV 1/2 Assay SURE CHECK® HIV Self-Test STAT-VIEW ® HIV 1/2 Assay Tropical & Fever Diseases Chagas STAT PAK ® Assay DPP® Zika IgM/IgG System DPP ® Zika IgM System DPP ® Ebola Antigen System DPP® ZCD IgM/IgG System Respiratory Diseases Status™ COVID-19/FLU Status™ FLU A & B DPP® SARS-CoV-2 IgM/IgG DPP® SARS-CoV-2 Antigen SCoV-2 Detect™ SCoV-2 Ag Detect™ Rapid Self-Test Advin COVID-19 Antigen Test @Home Handheld Analyzers DPP ® Micro Reader DPP ® Micro Reader II Veterinary Products DPP ® VetTB Assay for Elephants DPP ® VetTB Assay for Cervids Innovation Technology Patents Publications About Our Team Newsroom Careers Contact Us search Products Infectious Diseases DPP ® HIV-Syphilis DPP ® HIV 1/2 Assay DPP ® Syphilis Screen & Confirm HIV 1/2 STAT PAK ® Assay SURE CHECK ® HIV 1/2 Assay SURE CHECK® HIV Self-Test STAT-VIEW ® HIV 1/2 Assay Tropical & Fever Diseases Chagas STAT PAK ® Assay DPP® Zika IgM/IgG System DPP ® Zika IgM System DPP ® Ebola Antigen System DPP® ZCD IgM/IgG System Respiratory Diseases Status™ COVID-19/FLU Status™ FLU A & B DPP® SARS-CoV-2 IgM/IgG DPP® SARS-CoV-2 Antigen SCoV-2 Detect™ SCoV-2 Ag Detect™ Rapid Self-Test Advin COVID-19 Antigen Test @Home Handheld Analyzers DPP ® Micro Reader DPP ® Micro Reader II Veterinary Products DPP ® VetTB Assay for Elephants DPP ® VetTB Assay for Cervids Innovation Technology Patents Publications About Our Team Newsroom Careers Contact Us DPP HIV-Syphilis receives CLIA Waiver: The First & Only FDA Approved, CLIA Waived* HIV-Syphilis Rapid Test *CLIA Waived for fingerstick whole blood Learn More Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay Learn More Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK® Assay at Chembio Diagnostics Malaysia Facility Learn More 1 1 Announcing the receipt of CLIA Waiver for DPP HIV-Syphilis. Contact your local Chembio Representative for more information DPP ® HIV-Syphilis Stay up to date with our latest news. Chembio Biosynex Completes Acquisition of Chembio Diagnostics, Inc. Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG,… Chembio Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE)Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on… Chembio Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE)Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused…We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care. Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate. Our Core Values: RAPID” Relentless Accountable Passionate Innovative Diverse Learn More We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide. Career Opportunities Visit Our Other SItes Biosynex Chembio Germany Chembio Brazil Qualigen Diagnostics ProciseDx Company Chembio Diagnostic Systems, Inc. 3661 Horseblock Rd. Medford, NY 11763 +1-631-924-1135 SDS Documents Stay Connected Join Mailing List © 2024 Chembio Diagnostics, Inc.. Privacy Policy | Terms & Conditions twitter facebook linkedin Subscribe to the Chembio Mailing...